Boston College names Thomas Chiles the Deluca Professor of Biology

February 28, 2012

CHESTNUT HILL, MA -- Boston College Biology Department Chairman Thomas Chiles has been named the Dr. Michael E. and Dr. Salvatore A. DeLuca Professor of Biology, the university announced today.

Chiles, whose research into lymphocyte metabolism and cancer biology is funded by the National Cancer Institute, the National Institutes of Health and private foundations, said he was honored to receive the endowed professorship, which will support his ongoing research, particularly projects involving undergraduates.

"It is a privilege and an honor to be named the DeLuca Professor of Biology," said Chiles, who joined the BC faculty in 1992. "I'm grateful to the University and the DeLuca family for their ongoing support of my lab's work and the advancement of the biological sciences here at BC."

Chiles' research focuses on understanding how a subset of lymphocytes, also known as B cells, grow and survive. The white blood cells play a critical role in the infectious disease-fighting ability of the immune system. Chiles' research has focused on how B cells respond to their environment in order to produce antibodies and regulatory cytokines and are able to adapt to survive while fighting pathogens and infectious agents.

That research led Chiles into an area known as metabolomics to study how the B cell's metabolism changes in response to external cues such as pathogens in order to support its radical transformation to an antibody producing plasma cell. In collaboration with Chemistry Professor Mary Roberts, the research is also providing insight into how energy metabolism is altered in cancer cells to support their growth and survival.

Chiles is also part of a multi-disciplinary team of campus scientists developing the next generation of nanosensors capable of detecting minute amounts of cancer biomarkers that signal the presence of disease. Developed in collaboration with Biology Research Professor Dong Cai and Physics Professor Mike Naughton the biosensor could prove to be a valuable new diagnostic tool for the early detection of cancer.

The DeLuca professorship was established in 1996 through an endowment from Dr. Salvatore A. and Lucy DeLuca to honor the memory of their son, Michael, a 1986 BC graduate who died in 1991. BC Biology Prof. Marc A.T. Muskavitch was the inaugural holder of the chair.

David Quigley, dean of the College of Arts & Sciences, said the selection of Chiles to hold the DeLuca Professorship was fitting recognition of Chiles' work as a researcher, teacher, mentor and administrator.

"I can't think of a colleague more deserving of this honor than Thomas Chiles," said Quigley. "In his 20 years at Boston College, Thomas has devoted himself to his students and to the Biology Department. His committed leadership has been instrumental in the considerable progress we've been making in the natural sciences in recent years."

An avid runner, Chiles participates in at least one marathon a year, typically alternating between the New York City and Chicago marathons. He cites art and music as areas of interest outside of science. He and his wife, Sheryl, live in Norfolk with their three Portuguese water dogs.

A native Floridian who earned his doctorate from the College of Medicine at the University of Florida, Chiles grew up in Jacksonville's Northside neighborhood. He credited his high school advanced biology teacher, Clayton Linstram, with fueling his interest in studying biology at Florida. In Gainesville, professors Joseph Powell and Michael Kilberg added further support, he said.

"I've always been real curious about everything, but especially science," said Chiles. "There was a pilot light there and it caught and turned into a full blown furnace when I arrived on the University of Florida campus and I never looked back."
-end-


Boston College

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.